Correlation Engine 2.0
Clear Search sequence regions


  • antagonists heparin (1)
  • bapta (1)
  • Ca2 (4)
  • calcium (2)
  • ip3 receptor (1)
  • orexin b (1)
  • orexin receptors (2)
  • Orexins (2)
  • OX1R (4)
  • OX2R (1)
  • PKC (4)
  • rats (2)
  • receptors (2)
  • signal (1)
  • spinal cord (5)
  • ventral horn neurons (4)
  • Sizes of these terms reflect their relevance to your search.

    Orexin-A/B modulates multiple physical functions by activating their receptors (OX1R and OX2R), but its effects in the spinal cord motor control remain unknown. Using acute separation (by digestive enzyme) of cells and patch-clamp recordings, we aimed to investigate the effect and mechanisms of orexin-A on the glycine receptors in the spinal cord ventral horn neurons. Orexin-A potentiated the glycine currents by activating OX1R. In Ca2+-free extracellular solution, orexin-A still increased the glycine currents. While, the orexin-A-induced potentiation was blocked when Ca2+ was chelated by internal infusion of BAPTA, and the orexin-A effect was abolished by the IP3 receptor antagonists heparin and Xe-C. The PKC inhibitor Bis-IV nullified the orexin-A effect. In addition, orexin-A did not cause a further enhancement of the glycine currents after bath application of the PKC activator PMA. In conclusion, after OX1R is activated, a distinct IP3/Ca2+-dependent PKC signaling pathway, is likely responsible for the orexin-A potentiation on glycine currents in the spinal cord ventral horn neurons. Copyright © 2021 Elsevier Inc. All rights reserved.

    Citation

    Na Jin, Su-Yue Zhu, Xin-Yu Yang, Cheng Zhen, Yan Li, Huan-Huan Zhang, Ai-Ping Xu, Meng-Ya Wang, Chao Zheng. Orexin-A potentiates glycine currents by activating OX1R and IP3/Ca2+/PKC signaling pathways in spinal cord ventral horn neurons. Brain research bulletin. 2021 Apr;169:196-204

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33515654

    View Full Text